# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001370053-21-000056
Filing Date
2021-08-09
Accepted
2021-08-09 16:13:38
Documents
60
Period of Report
2021-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | anab-20210630.htm iXBRL | 10-Q | 1443388
2 | EX-10.19 | anaptysbio-firstamendmentx.htm | EX-10.19 | 26672
3 | EX-31.1 | anab-6302021x10qxexx311.htm | EX-31.1 | 8532
4 | EX-31.2 | anab-6302021x10qxexx312.htm | EX-31.2 | 8397
5 | EX-32.1 | anab-6302021x10qxexx321.htm | EX-32.1 | 5057
6 | EX-32.2 | anab-6302021x10qxexx322.htm | EX-32.2 | 4910
12 | PIPELINE CHART | anab-20210630_g1.jpg | GRAPHIC | 405788
13 | GRAPHIC | image_1.jpg | GRAPHIC | 95230
14 | GRAPHIC | image_3.jpg | GRAPHIC | 92954
| Complete submission text file | 0001370053-21-000056.txt |  | 7071631

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | anab-20210630.xsd | EX-101.SCH | 35040
8 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | anab-20210630_cal.xml | EX-101.CAL | 47340
9 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | anab-20210630_def.xml | EX-101.DEF | 132229
10 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | anab-20210630_lab.xml | EX-101.LAB | 450340
11 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | anab-20210630_pre.xml | EX-101.PRE | 270571
15 | EXTRACTED XBRL INSTANCE DOCUMENT | anab-20210630_htm.xml | XML | 1010327

Mailing Address 10770 WATERIDGE CIRCLE, SUITE 210 SAN DIEGO CA 92121
Business Address 10770 WATERIDGE CIRCLE, SUITE 210 SAN DIEGO CA 92121 858-362-6295
ANAPTYSBIO, INC (Filer) CIK: 0001370053 (see all company filings)

EIN.: 203828755 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37985 | Film No.: 211156641
SIC: 2834 Pharmaceutical Preparations